CCSAP
gene geneOn this page
Also known as FLJ41471CSAP
Summary
CCSAP (centriole, cilia and spindle associated protein, HGNC:29578) is a protein-coding gene on chromosome 1q42.13, encoding Centriole, cilia and spindle-associated protein (Q6IQ19). Plays a role in microtubule (MT) stabilization and this stabilization involves the maintenance of NUMA1 at the spindle poles.
Enables microtubule binding activity. Involved in mitotic spindle microtubule depolymerization and regulation of mitotic spindle assembly. Located in axon; ciliary transition zone; and cytoskeleton.
Source: NCBI Gene 126731 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 38 total
- MANE Select transcript:
NM_145257
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29578 |
| Approved symbol | CCSAP |
| Name | centriole, cilia and spindle associated protein |
| Location | 1q42.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ41471, CSAP |
| Ensembl gene | ENSG00000154429 |
| Ensembl biotype | protein_coding |
| OMIM | 616762 |
| Entrez | 126731 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000284617, ENST00000366686, ENST00000366687, ENST00000483092
RefSeq mRNA: 2 — MANE Select: NM_145257
NM_001410936, NM_145257
CCDS: CCDS1577, CCDS91172
Canonical transcript exons
ENST00000284617 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001069973 | 229321015 | 229325411 |
| ENSE00001431026 | 229342912 | 229343047 |
| ENSE00003890818 | 229326738 | 229327006 |
| ENSE00003892944 | 229342099 | 229342513 |
Expression profiles
Bgee: expression breadth ubiquitous, 252 present calls, max score 97.55.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.6557 / max 194.2457, expressed in 1637 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 17866 | 7.7147 | 1533 |
| 17869 | 3.1332 | 676 |
| 17867 | 0.3888 | 207 |
| 17860 | 0.2162 | 73 |
| 17871 | 0.1659 | 58 |
| 17870 | 0.0371 | 11 |
Top tissues by expression
258 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| Brodmann (1909) area 46 | UBERON:0006483 | 97.55 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 97.53 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 97.32 | gold quality |
| cortical plate | UBERON:0005343 | 97.27 | gold quality |
| secondary oocyte | CL:0000655 | 96.69 | gold quality |
| postcentral gyrus | UBERON:0002581 | 96.68 | gold quality |
| entorhinal cortex | UBERON:0002728 | 96.46 | gold quality |
| parietal lobe | UBERON:0001872 | 96.40 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 96.21 | gold quality |
| ganglionic eminence | UBERON:0004023 | 95.35 | gold quality |
| embryo | UBERON:0000922 | 95.34 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 94.77 | gold quality |
| retina | UBERON:0000966 | 94.75 | gold quality |
| upper arm skin | UBERON:0004263 | 94.55 | gold quality |
| endothelial cell | CL:0000115 | 94.46 | gold quality |
| occipital lobe | UBERON:0002021 | 94.34 | gold quality |
| primary visual cortex | UBERON:0002436 | 93.91 | gold quality |
| oocyte | CL:0000023 | 93.89 | gold quality |
| placenta | UBERON:0001987 | 93.49 | gold quality |
| corpus callosum | UBERON:0002336 | 93.32 | gold quality |
| upper leg skin | UBERON:0004262 | 93.29 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 93.20 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 93.14 | gold quality |
| thymus | UBERON:0002370 | 93.04 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 92.11 | gold quality |
| globus pallidus | UBERON:0001875 | 91.91 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 91.71 | gold quality |
| medial globus pallidus | UBERON:0002477 | 91.61 | gold quality |
| pons | UBERON:0000988 | 91.55 | gold quality |
| cerebellum | UBERON:0002037 | 90.89 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.41 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
204 targeting CCSAP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-520G-5P | 99.99 | 66.76 | 658 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
Literature-anchored findings (GeneRIF, showing 2)
- The tubulin binding protein CSAP associates with mitotic microtubules around centrosomes to stabilize mitotic microtubules during mitosis, ensuring proper bipolar spindle formation and maintenance. (PMID:26562023)
- Binding of CSAP to TTLL5 promotes relocalization of TTLL5 toward microtubules. (PMID:30517872)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ccsapa | ENSDARG00000025325 |
| danio_rerio | ccsapb | ENSDARG00000040085 |
| mus_musculus | Ccsap | ENSMUSG00000031971 |
| rattus_norvegicus | ENSRNOG00000074620 |
Protein
Protein identifiers
Centriole, cilia and spindle-associated protein — Q6IQ19 (reviewed: Q6IQ19)
All UniProt accessions (1): Q6IQ19
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in microtubule (MT) stabilization and this stabilization involves the maintenance of NUMA1 at the spindle poles. Colocalizes with polyglutamylated MTs to promote MT stabilization and regulate bipolar spindle formation in mitosis. Binding of CCSAP to centrosomes and the spindle around centrosomes during mitosis inhibits MT depolymerization, thereby stabilizing the mitotic spindle. May play a role in embryonic development. May be required for proper cilia beating.
Subunit / interactions. Associates with microtubules; the association occurs on polyglutamylated tubulin.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Centriole. Spindle. Cilium basal body. Cilium axoneme. Cell projection. Axon. Cilium.
Similarity. Belongs to the CCSAP family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6IQ19-1 | 1 | yes |
| Q6IQ19-2 | 2 | |
| Q6IQ19-3 | 3 | |
| Q6IQ19-4 | 4 |
RefSeq proteins (2): NP_001397865, NP_660300* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029774 | CSAP | Family |
Pfam: PF15748
UniProt features (20 total): compositionally biased region 6, splice variant 6, region of interest 2, short sequence motif 2, chain 1, modified residue 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6IQ19-F1 | 64.61 | 0.16 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 1
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 196 (showing top):
GOBP_CHROMOSOME_ORGANIZATION, GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, AAGCCAT_MIR135A_MIR135B, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOCC_MICROTUBULE_ORGANIZING_CENTER, SENESE_HDAC1_AND_HDAC2_TARGETS_DN, GOBP_MITOTIC_SPINDLE_ASSEMBLY, GOBP_ORGANELLE_FISSION, GOBP_MICROTUBULE_DEPOLYMERIZATION, GOBP_REGULATION_OF_SPINDLE_ORGANIZATION, FISCHER_G2_M_CELL_CYCLE, GROSS_HYPOXIA_VIA_HIF1A_DN
GO Biological Process (4): regulation of embryonic development (GO:0045995), cell division (GO:0051301), regulation of mitotic spindle assembly (GO:1901673), mitotic spindle microtubule depolymerization (GO:1990755)
GO Molecular Function (1): microtubule binding (GO:0008017)
GO Cellular Component (14): centrosome (GO:0005813), centriole (GO:0005814), spindle (GO:0005819), cilium (GO:0005929), axoneme (GO:0005930), axon (GO:0030424), ciliary transition zone (GO:0035869), ciliary basal body (GO:0036064), mitotic spindle astral microtubule (GO:0061673), mitotic spindle (GO:0072686), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), microtubule (GO:0005874), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| microtubule organizing center | 3 |
| intracellular membraneless organelle | 3 |
| microtubule cytoskeleton | 2 |
| cilium | 2 |
| embryo development | 1 |
| regulation of multicellular organismal development | 1 |
| cellular process | 1 |
| regulation of mitotic spindle organization | 1 |
| regulation of spindle assembly | 1 |
| mitotic spindle assembly | 1 |
| microtubule depolymerization | 1 |
| tubulin binding | 1 |
| centriole | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| neuron projection | 1 |
| astral microtubule | 1 |
| mitotic spindle | 1 |
| spindle | 1 |
| intracellular anatomical structure | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
360 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCSAP | CEP72 | Q9P209 | 437 |
| CCSAP | EOLA2 | Q96DE9 | 432 |
| CCSAP | CEP120 | Q8N960 | 431 |
| CCSAP | CEP85L | Q5SZL2 | 410 |
| CCSAP | SPICE1 | Q8N0Z3 | 409 |
| CCSAP | FER1L6 | Q2WGJ9 | 352 |
| CCSAP | CEP85 | Q6P2H3 | 339 |
| CCSAP | HDHD5 | Q9BXW7 | 336 |
| CCSAP | RASL11B | Q9BPW5 | 334 |
| CCSAP | CEP170B | Q9Y4F5 | 332 |
| CCSAP | HOOK1 | Q9UJC3 | 331 |
| CCSAP | ZSWIM3 | Q96MP5 | 324 |
| CCSAP | SESN3 | P58005 | 312 |
| CCSAP | C9orf40 | Q8IXQ3 | 311 |
| CCSAP | ZSCAN5A | Q9BUG6 | 311 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HDAC1 | ZBTB43 | psi-mi:“MI:0914”(association) | 0.350 |
| CEP63 | CIBAR1 | psi-mi:“MI:0914”(association) | 0.350 |
| DISC1 | CCSAP | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCSAP | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (5): CCSAP (Affinity Capture-RNA), CCSAP (Affinity Capture-RNA), CCSAP (Affinity Capture-MS), CCSAP (Proximity Label-MS), CCSAP (Affinity Capture-RNA)
ESM2 similar proteins: A0A1L8HTT5, A0A8I5ZM56, A2AJI0, B0KYV5, B0S4Q5, C0SPG1, D3ZUI5, E1C2Q8, F1LR10, K7SGN7, O70240, O73737, O75128, O88566, P34926, P51826, Q0P591, Q13625, Q14BB9, Q15554, Q3KQU3, Q5PQN4, Q5PR69, Q5RC32, Q5ZJJ1, Q5ZMW6, Q63560, Q69Z61, Q6IQ19, Q6NV74, Q6ZU35, Q7T3T9, Q7T3U0, Q7TSJ2, Q80XA6, Q86XL3, Q8CG79, Q8N7J2, Q8N9B5, Q8NFH8
Diamond homologs: Q6IQ19, Q6P3G4, Q8QZT2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
38 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 33 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
800 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:229325199:CA:C | donor_gain | 1.0000 |
| 1:229326783:T:TA | donor_gain | 1.0000 |
| 1:229326870:TTTG:T | donor_gain | 1.0000 |
| 1:229327010:T:TC | acceptor_gain | 1.0000 |
| 1:229325245:G:A | donor_gain | 0.9900 |
| 1:229326881:T:A | donor_gain | 0.9900 |
| 1:229327007:C:CC | acceptor_gain | 0.9900 |
| 1:229327008:T:C | acceptor_gain | 0.9900 |
| 1:229327010:T:C | acceptor_gain | 0.9900 |
| 1:229327432:TC:T | donor_gain | 0.9900 |
| 1:229327433:CC:C | donor_gain | 0.9900 |
| 1:229328848:A:AC | donor_gain | 0.9900 |
| 1:229328856:G:C | donor_gain | 0.9900 |
| 1:229328877:T:TA | donor_gain | 0.9900 |
| 1:229326732:GCGCA:G | donor_loss | 0.9800 |
| 1:229326733:CGCAC:C | donor_loss | 0.9800 |
| 1:229326734:GCA:G | donor_loss | 0.9800 |
| 1:229326735:CACCT:C | donor_loss | 0.9800 |
| 1:229326736:ACCT:A | donor_loss | 0.9800 |
| 1:229326737:CCTC:C | donor_loss | 0.9800 |
| 1:229327002:CAGTG:C | acceptor_gain | 0.9800 |
| 1:229327395:T:TA | donor_gain | 0.9800 |
| 1:229328926:TTAA:T | donor_gain | 0.9800 |
| 1:229342093:GGGTA:G | donor_loss | 0.9800 |
| 1:229342094:GGTAC:G | donor_loss | 0.9800 |
| 1:229342095:GTAC:G | donor_loss | 0.9800 |
| 1:229342096:TA:T | donor_loss | 0.9800 |
| 1:229342098:C:CT | donor_loss | 0.9800 |
| 1:229325141:TAA:T | donor_gain | 0.9700 |
| 1:229325142:AAA:A | donor_gain | 0.9700 |
AlphaMissense
1731 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:229325264:A:G | Y262H | 0.998 |
| 1:229342435:A:G | Y11H | 0.998 |
| 1:229325263:T:C | Y262C | 0.997 |
| 1:229326763:A:T | V204D | 0.997 |
| 1:229342357:G:T | R37S | 0.997 |
| 1:229325276:A:G | W258R | 0.996 |
| 1:229325276:A:T | W258R | 0.996 |
| 1:229326822:A:C | F184L | 0.996 |
| 1:229326822:A:T | F184L | 0.996 |
| 1:229326824:A:G | F184L | 0.996 |
| 1:229342343:C:A | E41D | 0.996 |
| 1:229342343:C:G | E41D | 0.996 |
| 1:229342366:G:T | R34S | 0.996 |
| 1:229325252:A:C | Y266D | 0.995 |
| 1:229325269:G:A | T260I | 0.995 |
| 1:229325379:T:A | R223S | 0.995 |
| 1:229325379:T:G | R223S | 0.995 |
| 1:229342434:T:C | Y11C | 0.995 |
| 1:229325376:T:A | R224S | 0.994 |
| 1:229325376:T:G | R224S | 0.994 |
| 1:229325410:A:G | I213T | 0.994 |
| 1:229326820:G:T | A185D | 0.994 |
| 1:229342336:G:C | H44D | 0.994 |
| 1:229342344:T:A | E41V | 0.994 |
| 1:229325274:C:A | W258C | 0.993 |
| 1:229325274:C:G | W258C | 0.993 |
| 1:229325410:A:C | I213S | 0.993 |
| 1:229326765:G:C | N203K | 0.993 |
| 1:229326765:G:T | N203K | 0.993 |
| 1:229342387:A:C | Y27D | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000013783 (1:229338162 G>A), RS1000035290 (1:229340594 C>A), RS1000254981 (1:229343847 A>T), RS1000292018 (1:229332238 G>A), RS1000400820 (1:229327977 T>C), RS1000410920 (1:229327666 G>A), RS1000598935 (1:229333198 C>T), RS1000769006 (1:229327286 T>C), RS1000803239 (1:229327561 G>A), RS1001033082 (1:229333237 C>T), RS1001497247 (1:229340045 T>C), RS1001714263 (1:229331904 C>G), RS1001828770 (1:229333234 C>A,T), RS1001947606 (1:229327634 C>A), RS1001957758 (1:229327324 G>A)
Disease associations
OMIM: gene MIM:616762 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation, increases expression | 2 |
| sodium arsenite | increases expression, affects cotreatment, increases abundance | 2 |
| Acetaminophen | increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | increases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| hydroquinone | decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| torcetrapib | increases expression | 1 |
| abrine | decreases expression | 1 |
| bisphenol S | affects cotreatment, decreases methylation | 1 |
| Sunitinib | decreases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Calcitriol | decreases expression, affects cotreatment | 1 |
| Cisplatin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Gallic Acid | decreases expression | 1 |
| Hydrogen Peroxide | increases expression | 1 |
| Iron | increases expression | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| Smoke | decreases expression | 1 |
| Dihydrotestosterone | increases expression | 1 |
| Testosterone | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.